Molecular fingerprint of breast tumors linked to immune response in bloodstream

September 28, 2017, Public Library of Science
MIxT identifies links between molecular processes in breast cancer tumors and blood cells. Credit: Vanessa Dumeaux

Using newly developed software, researchers have shown that genes and molecular processes in breast cancer tumor cells are tightly linked to genes and processes in blood cells, including immune system cells. The findings are published in PLOS Computational Biology.

Even if a tumor has not metastasized, its effects extend far beyond the part of the body in which it is found. For instance, a tumor influences the expression of genes in that are involved in the body's response to cancer. These cells circulate throughout the body in the bloodstream.

In the new study, a team led by Vanessa Dumeaux during her time at McGill University examined links between gene expression in breast cancer tumors and in the bloodstream. They built a new software tool called MIxT (Matched Interactions across Tissues) that uses computational and statistical methods to find and investigate links between gene expression in different body tissues.

The team used MIxT to analyze gene expression according to RNA sequences found in blood and tumor samples from 173 . The software allowed them to cluster genes into groups associated with specific and see which processes in tumors and were associated with each other.

The analysis showed that links between molecular processes in breast cancer tumors and the bloodstream do exist, but that they vary according to the tumor subtype. For instance, the researchers found immune system-suppressing processes operating in conjunction with certain breast cancer subtypes, including the basal breast cancer subtype.

"This effort moves the community beyond the barriers of most previous molecular studies that focused exclusively on immune cells in the tumor microenvironment, providing a broader picture of how our bodies and immune system respond to the challenges of the presence of a particular tumor," Dumeaux says.

The findings could lead to future investigation into potential new ways to treat and monitor by looking outside the tumor and exploiting the patient's systemic immune system response.

Explore further: Study sheds light on why some breast cancers have limited response to immunotherapy

More information: Dumeaux V, Fjukstad B, Fjosne HE, Frantzen J-O, Holmen MM, Rodegerdts E, et al. (2017) Interactions between the tumor and the blood systemic response of breast cancer patients. PLoS Comput Biol 13(9): e1005680. doi.org/10.1371/journal.pcbi.1005680

Related Stories

Study sheds light on why some breast cancers have limited response to immunotherapy

August 21, 2017
UNC Lineberger Comprehensive Cancer Center researchers have identified a possible reason why some aggressive breast cancers are unresponsive to certain immunotherapy treatments, as well as a potential solution.

Silencing cancer cell communication may reduce the growth of tumors

January 30, 2017
In several types of cancer, elevated expression of the chemokine receptor CCR4 in tumors is associated with poor patient outcomes. Communication through CCR4 may be one mechanism that cancer cells use to create a pro-tumor ...

Immune-response genes affecting breast tumor eradication

May 3, 2012
Breast cancer patients whose tumors express high levels of genes related to immune response are more likely to have their tumor completely eradicated by pre-operative chemotherapy compared to patients with low expression ...

The paradoxical roles of well-known cancer genes are mediated by oxygen levels in breast cancer

January 4, 2017
Oxygen deprivation, or hypoxia, has been identified by A*STAR researchers as a key factor in switching the function of major cancer genes from tumor-promoting to tumor-suppressing in a breast cancer subtype, suggesting the ...

Blood vessels and the immune system talk to each other; implications for cancer treatment

April 3, 2017
Some cancer therapies aim at stopping tumor growth by affecting the blood vessels that nurture the tumor mass, while others act on the immune system attempting to eliminate the tumor. Researchers at Baylor College of Medicine ...

Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor

May 16, 2016
Not every breast cancer tumor follows the same path to grow. Some tumors have the assistance of myeloid-derived suppressor cells (MDSCs), a diverse type of immune cell involved in the suppression of the body's response against ...

Recommended for you

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Experimental arthritis drug prevents stem cell transplant complication

April 24, 2018
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows. ...

Scientists develop a new model for glioblastoma using gene-edited organoids

April 24, 2018
Glioblastoma multiforme (GBM) is an incredibly deadly brain cancer and presents a serious black box challenge. It's virtually impossible to observe how these tumors operate in their natural environment and animal models don't ...

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.